Quince Therapeutics, Inc.

QNCX.US ยท Healthcare ยท Biotechnology ยท USD ยท Fundamentals
Asset-light

Physical assets are 1.1% of total assets, a light footprint. Capex is 2.48x depreciation and free cash flow yield is negative, so the physical base is expanding and consuming cash.

Fixed-asset turnover is 0.00x. Compare it with other names in the same basket.

Physical asset ratio
1.1%
Net PP&E plus inventory, divided by total assets. Above 50% is a heavy footprint.
Fixed asset turnover
0.00x
Revenue per dollar of the physical asset base.
Capex / D&A
2.48x
Above 1.0x means the physical base is being replaced or expanded.
Tangible book / share
-$413.33
Assets minus goodwill, intangibles, and liabilities, per share.
Price / tangible book
โ€”
Price $33.23.
Fixed-charge coverage
โ€”
EBITDA minus capex, divided by interest plus short-term debt.
FCF yield
-129.5%
Latest free cash flow divided by current market cap ($32.27M).
ROIC
โ€”
After-tax operating income over equity plus debt minus cash. Operating income / net PP&E is -48.12x.

Footprint and return

Turnover and reinvestment

Year Physical FAT Capex/D&A TBV/sh Coverage FCF ROIC EBIT/PP&E
2018 0.4% 0.00x 4.16x $662.80 -12.83x -$11.91M โ€” -42.82x
2019 1.1% 0.00x 0.29x $1.21K -17.84x -$33.33M โ€” -29.36x
2020 0.6% 0.00x 0.16x $1.18K -34.45x -$50.87M โ€” -71.66x
2021 2.8% 0.00x 0.52x $798.06 -80.59x -$63.11M โ€” -63.25x
2022 2.9% 0.00x 0.65x $565.39 -50.07x -$44.17M โ€” -76.05x
2023 0.3% 0.00x 0.50x $20.34 โ€” -$18.45M โ€” -55.93x
2024 0.7% 0.00x 1.38x -$138.22 โ€” -$32.16M โ€” -70.46x
2025 1.1% 0.00x 2.48x -$413.33 โ€” -$41.78M โ€” -48.12x
  • Inventory was missing and treated as zero in the physical asset ratio.
  • Receivables are larger than the physical asset base, so a finance or credit book may sit outside the physical ratio and inside the debt used for coverage.
  • Principal due is the current portion of debt.
Latest year inputs (2025)
Net PP&E: $1.05M
Inventory: $0.00
Total assets: $93.52M
Goodwill: $0.00
Intangibles: $67.82M
Liabilities: $129.24M
Tangible book: -$103.53M
Shares: 250,485
Revenue: $0.00
Capex: $352.00K
D&A: $142.00K
EBITDA: -$80.62M
Interest: โ€”
Short-term debt: $18.03M
Free cash flow: -$41.78M
Operating income: -$50.43M
Invested capital: โ€”
Tax rate: โ€”